Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CRMDCorMedix Inc.

Nasdaq · CIK 0001410098
Filer categoryNon-accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts616

Identity from submissions API

NameCorMedix Inc.
CIK0001410098
TickersCRMD
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone908-517-9500
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • None listed.
Business address
389 INTERPACE PKWY, SUITE 450
PARSIPPANY
NJ
07054
NJ
Mailing address
389 INTERPACE PKWY, SUITE 450
PARSIPPANY
NJ
07054
NJ

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1149 filing rows loaded from submissions recent; extra archives: CIK0001410098-submissions-001.json (147 filings, 2007-08-14 to 2012-11-11).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 4 xslF345X06/ownership.xml 0001213900-26-122769 4630
2026-11-20 4 xslF345X06/ownership.xml 0001213900-26-122587 6329
2026-11-18 4 xslF345X06/ownership.xml 0001213900-26-121895 6908
2026-11-16 4 xslF345X06/ownership.xml 0001213900-26-120120 5105
2026-11-16 DFAN14A SOLICITING MATERIAL PURSUANT TO 240.14A-12 0001213900-26-120019 126227
2026-11-16 DEFA14A CURRENT REPORT 0001213900-26-120018 001-34673 261554907 34 152610
2026-11-16 8-K CURRENT REPORT 7.01,9.01 0001213900-26-120016 001-34673 261554906 34 350572 1 1
2026-11-12 10-Q 10-Q 0001410098-26-000067 001-34673 261543565 34 8364849 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001410098-26-000063 001-34673 261543401 34 416594 1 1
2026-11-10 DEFA14A CURRENT REPORT 0001213900-26-118114 001-34673 261541556 34 10920622
2026-11-10 8-K CURRENT REPORT 7.01,9.01 0001213900-26-118109 001-34673 261541536 34 11121751 1 1
2026-11-09 DEFA14A CURRENT REPORT 0001213900-26-117216 001-34673 261533860 34 2718998
2026-11-09 8-K CURRENT REPORT 1.01,2.03,3.02,7.01,9.01 0001213900-26-117213 001-34673 261533846 34 3464365 1 1
2026-11-02 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-26-114665 001-34673 261509907 34 224492 1 1
2026-10-19 8-K CURRENT REPORT 7.01,9.01 0001213900-26-110477 001-34673 261467541 34 227015 1 1
2026-09-18 4 xslF345X06/ownership.xml 0001213900-26-101594 7219
2026-09-01 4 xslF345X06/ownership.xml 0001213900-26-096386 4630
2026-09-01 4 xslF345X06/ownership.xml 0001213900-26-096385 4900
2026-09-01 4 xslF345X06/ownership.xml 0001213900-26-096383 4628
2026-08-13 10-Q 10-Q 0001410098-26-000056 001-34673 261270145 34 8353559 1 1
2026-08-13 8-K 8-K 2.02,9.01 0001410098-26-000054 001-34673 261270072 34 402069 1 1
2026-08-07 8-K 8-K 8.01,9.01 0001410098-26-000044 001-34673 261254283 34 602224 1 1
2026-07-02 8-K 8-K 8.01 0001410098-26-000040 001-34673 261151891 34 143187 1 1
2026-07-01 8-K 8-K 4.01 0001410098-26-000037 001-34673 261142568 34 247979 1 1
2026-06-25 S-8 POS S-8 POS 0001410098-26-000032 333-170498 261122449 33 23826
2026-06-24 8-K 8-K 5.07 0001410098-26-000028 001-34673 261116243 34 188278 1 1
2026-06-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002063837-26-000003 005-85411 261085861 34 6104
2026-06-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002063837-26-000002 005-85411 261085827 34 5528
2026-06-08 8-K CURRENT REPORT 7.01,9.01 0001213900-26-066061 001-34673 261071141 34 247460 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002026 005-85411 26982631 34 11350
2026-05-14 10-Q 10-Q 0001410098-26-000021 001-34673 26975913 34 6821111 1 1
2026-05-14 8-K 8-K 2.02,9.01 0001410098-26-000020 001-34673 26975869 34 356518 1 1
2026-04-29 ARS ARS 0001213900-26-049323 001-34673 26916429 34 512128
2026-04-29 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-049317 001-34673 26916373 34 5458136
2026-04-29 DEF 14A PROXY STATEMENT 0001213900-26-049311 001-34673 26916292 34 10575331 1 1
2026-04-27 8-K CURRENT REPORT 7.01,9.01 0001213900-26-047748 001-34673 26896627 34 252366 1 1
2026-04-17 PRE 14A PROXY STATEMENT 0001213900-26-045165 001-34673 26871745 34 10592977 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001102 005-85411 26799828 34 7118
2026-03-06 8-K CURRENT REPORT 7.01,9.01 0001213900-26-024777 001-34673 26732117 34 22589554 1 1
2026-03-05 10-K ANNUAL REPORT 0001213900-26-023889 001-34673 26724290 34 10165692 1 1
2026-03-05 8-K CURRENT REPORT 2.02,9.01 0001213900-26-023881 001-34673 26724223 34 306265 1 1
2026-02-06 4 xslF345X05/ownership.xml 0001213900-26-013408 5056
2026-02-06 4 xslF345X05/ownership.xml 0001213900-26-013407 5244
2026-02-06 4 xslF345X05/ownership.xml 0001213900-26-013406 5023
2026-01-27 4 xslF345X05/ownership.xml 0001213900-26-008482 15135
2026-01-27 4 xslF345X05/ownership.xml 0001213900-26-008480 15114
2026-01-27 4 xslF345X05/ownership.xml 0001213900-26-008479 6731
2026-01-27 4 xslF345X05/ownership.xml 0001213900-26-008478 6511
2026-01-27 4 OWNERSHIP DOCUMENT 0001213900-26-008473 15089
2026-01-27 4 OWNERSHIP DOCUMENT 0001213900-26-008476 4898
2026-01-27 4 OWNERSHIP DOCUMENT 0001213900-26-008474 6594
2026-01-27 4 OWNERSHIP DOCUMENT 0001213900-26-008475 13208
2026-01-27 4 OWNERSHIP DOCUMENT 0001213900-26-008477 13120
2026-01-27 4 OWNERSHIP DOCUMENT 0001213900-26-008472 13234
2026-01-22 4 xslF345X05/ownership.xml 0001213900-26-006876 13457
2026-01-21 144 xsl144X01/primary_doc.xml 0001628280-26-002900 001-34673 26548469 33 6233
2026-01-20 4 xslF345X05/ownership.xml 0001213900-26-005426 13444
2026-01-20 4 xslF345X05/ownership.xml 0001213900-26-005425 18616
2026-01-15 4 xslF345X05/ownership.xml 0001213900-26-004857 5005
2026-01-15 3 xslF345X02/ownership.xml 0001213900-26-004855 11378
2026-01-14 4 xslF345X05/ownership.xml 0001213900-26-004470 17605
2026-01-08 8-K CURRENT REPORT 2.02,5.02,8.01,9.01 0001213900-26-002350 001-34673 26517496 34 297463 1 1
2026-01-06 4 xslF345X05/ownership.xml 0001213900-26-001938 4736
2026-01-06 4 xslF345X05/ownership.xml 0001213900-26-001937 4568
2026-01-02 4 xslF345X05/ownership.xml 0001213900-26-000712 8337
2026-01-02 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002063837-26-000001 005-85411 26501130 34 6090
2025-12-30 144 xsl144X01/primary_doc.xml 0001628280-25-059113 001-34673 251614631 33 4376
2025-12-19 4 xslF345X05/ownership.xml 0001213900-25-124063 8996
2025-12-18 144 xsl144X01/primary_doc.xml 0001628280-25-057973 001-34673 251583545 33 4333
2025-12-11 4 xslF345X05/ownership.xml 0001213900-25-120378 12474
2025-12-10 4 xslF345X05/ownership.xml 0001213900-25-120296 6680
2025-12-09 144 xsl144X01/primary_doc.xml 0001628280-25-056128 001-34673 251559665 33 5594
2025-12-09 144 xsl144X01/primary_doc.xml 0001959173-25-007601 001-34673 251559434 33 20793
2025-12-04 4 xslF345X05/ownership.xml 0001213900-25-118433 15734
2025-12-01 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005229 005-85411 251539998 34 11189
2025-11-26 4 xslF345X05/ownership.xml 0001213900-25-115725 19919
2025-11-24 144 xsl144X01/primary_doc.xml 0001628280-25-053802 001-34673 251513136 33 4326
2025-11-18 4 xslF345X05/ownership.xml 0001213900-25-112316 4982
2025-11-14 144 xsl144X01/primary_doc.xml 0001965301-25-000173 001-34673 251483757 33 7903
2025-11-13 S-8 REGISTRATION STATEMENT 0001213900-25-110086 333-291512 251479482 33 205552 1 1
2025-11-12 10-Q QUARTERLY REPORT 0001213900-25-108777 001-34673 251469218 34 8547887 1 1
2025-11-12 8-K CURRENT REPORT 2.02,9.01 0001213900-25-108716 001-34673 251468907 34 309621 1 1
2025-11-10 144 xsl144X01/primary_doc.xml 0001628280-25-051155 001-34673 251467331 33 5924
2025-11-06 144 xsl144X01/primary_doc.xml 0001628280-25-050229 001-34673 251458849 33 4731
2025-10-27 4 xslF345X05/ownership.xml 0001213900-25-102764 6862
2025-10-24 DEF 14A PROXY STATEMENT 0001213900-25-101906 001-34673 251414382 34 3693335
2025-10-20 8-K CURRENT REPORT 2.02,9.01 0001213900-25-100156 001-34673 251402371 34 235117 1 1
2025-10-14 PRER14A PROXY STATEMENT 0001213900-25-098867 001-34673 251392667 34 3702280
2025-10-07 S-3ASR REGISTRATION STATEMENT 0001213900-25-097101 333-290756 251380570 33 535874 1 1
2025-10-07 RW WITHDRAWAL REQUEST 0001213900-25-097097 333-290721 251380533 NE 6294
2025-10-06 S-3ASR REGISTRATION STATEMENT 0001213900-25-096230 333-290721 251375359 33 516086 1 1
2025-10-06 RW REGISTRATION WITHDRAWAL REQUEST 0001213900-25-096229 333-290636 251375357 NE 6551
2025-09-30 S-3 REGISTRATION STATEMENT 0001213900-25-094067 333-290636 251361498 33 466820 1 1
2025-09-30 8-K/A AMENDMENT NO. 1 TO FORM 8-K 9.01 0001213900-25-093983 001-34673 251360934 34 1120444 1 1
2025-09-18 4 xslF345X05/ownership.xml 0001213900-25-089216 6929
2025-09-16 4 xslF345X05/ownership.xml 0001213900-25-088337 8901
2025-09-15 PRE 14A PROXY STATEMENT 0001213900-25-087735 001-34673 251315128 34 3266132
2025-09-12 4 xslF345X05/ownership.xml 0001213900-25-087374 8985
2025-09-12 4 xslF345X05/ownership.xml 0001213900-25-087371 4705
2025-09-12 3 xslF345X02/ownership.xml 0001213900-25-087370 001-35068 251313040 34 3943
2025-09-12 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-087369 29917
2025-09-12 144 xsl144X01/primary_doc.xml 0002007317-25-001084 001-34673 251311983 33 4242
2025-09-12 144 xsl144X01/primary_doc.xml 0002007317-25-001082 001-34673 251311892 33 4197
2025-09-11 4 xslF345X05/ownership.xml 0001213900-25-087014 10461
2025-09-11 4 xslF345X05/ownership.xml 0001213900-25-087013 14715
2025-09-09 144 xsl144X01/primary_doc.xml 0002007317-25-001058 001-34673 251303862 33 4258
2025-09-09 144 xsl144X01/primary_doc.xml 0002007317-25-001057 001-34673 251303855 33 4428
2025-09-08 4/A xslF345X05/ownership.xml 0001213900-25-085282 5248
2025-09-08 4/A xslF345X05/ownership.xml 0001213900-25-085280 5080
2025-09-03 4 OWNERSHIP DOCUMENT 0001213900-25-084129 5304
2025-09-03 4 OWNERSHIP DOCUMENT 0001213900-25-084126 5136
2025-09-03 4 OWNERSHIP DOCUMENT 0001213900-25-084123 5052
2025-09-03 3 xslF345X02/ownership.xml 0001213900-25-084094 2987
2025-09-03 144 xsl144X01/primary_doc.xml 0002007317-25-001021 001-34673 251290283 33 4232
2025-09-02 8-K CURRENT REPORT 1.01,2.01,3.02,5.02,7.01,9.01 0001213900-25-082956 001-34673 251283185 34 1464495 1 1
2025-08-12 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-25-075010 001-34673 251207451 34 1192404 1 1
2025-08-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002063837-25-000003 005-85411 251196885 34 6341
2025-08-07 10-Q QUARTERLY REPORT 0001213900-25-072843 001-34673 251191880 34 6215102 1 1
2025-08-07 8-K CURRENT REPORT 1.01,2.02,3.02,7.01,8.01,9.01 0001213900-25-072814 001-34673 251191612 34 11434302 1 1
2025-06-30 8-K CURRENT REPORT 8.01,9.01 0001213900-25-059702 001-34673 251092735 34 573329 1 1
2025-06-30 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-059256 333-279277 251088826 33 476906
2025-06-26 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-058406 333-279277 251080580 33 477726
2025-06-25 8-K CURRENT REPORT 5.07 0001213900-25-057451 001-34673 251070823 34 196403 1 1
2025-06-23 8-K CURRENT REPORT 7.01,9.01 0001213900-25-056415 001-34673 251062982 34 225035 1 1
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002063837-25-000002 005-85411 25932519 34 6320
2025-05-06 10-Q QUARTERLY REPORT 0001213900-25-039908 001-34673 25915390 34 4813013 1 1
2025-05-06 8-K CURRENT REPORT 2.02,9.01 0001213900-25-039903 001-34673 25915281 34 270672 1 1
2025-04-28 ARS ARS 0001213900-25-036117 001-34673 25880932 34 403902
2025-04-28 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-036112 001-34673 25880885 34 4228176
2025-04-28 DEF 14A PROXY STATEMENT 0001213900-25-036108 001-34673 25880858 34 9151422 1 1
2025-04-22 8-K CURRENT REPORT 4.01,9.01 0001213900-25-034219 001-34673 25858078 34 203566 1 1
2025-04-08 8-K CURRENT REPORT 2.02,9.01 0001213900-25-029629 001-34673 25820311 34 223554 1 1
2025-04-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002063837-25-000001 005-85411 25812701 34 6369
2025-04-03 4 xslF345X05/ownership.xml 0001213900-25-028653 8838
2025-04-02 4 xslF345X05/ownership.xml 0001213900-25-027598 7243
2025-03-25 10-K ANNUAL REPORT 0001013762-25-001852 001-34673 25765980 34 7023876 1 1
2025-03-25 8-K CURRENT REPORT 2.02,9.01 0001013762-25-001844 001-34673 25765907 34 281053 1 1
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001199 005-85411 25592218 34 11786
2025-01-22 4 xslF345X05/ownership.xml 0001213900-25-005675 6536
2025-01-22 4 xslF345X05/ownership.xml 0001213900-25-005674 4946
2025-01-22 4 xslF345X05/ownership.xml 0001213900-25-005673 4904
2025-01-22 4 xslF345X05/ownership.xml 0001213900-25-005672 4892
2025-01-22 4 xslF345X05/ownership.xml 0001213900-25-005671 6698
2025-01-22 4 xslF345X05/ownership.xml 0001213900-25-005669 6593
2025-01-22 4 xslF345X05/ownership.xml 0001213900-25-005667 4910
2025-01-14 4 xslF345X05/ownership.xml 0001213900-25-003535 4543
2025-01-14 4 xslF345X05/ownership.xml 0001213900-25-003534 4518
2025-01-14 4 xslF345X05/ownership.xml 0001213900-25-003533 4538
2025-01-14 4 xslF345X05/ownership.xml 0001213900-25-003532 4722
2025-01-07 8-K CURRENT REPORT 2.02,9.01 0001213900-25-001392 001-34673 25513488 34 240728 1 1
2025-01-06 4 OWNERSHIP DOCUMENT 0001213900-25-001358 6583
2025-01-06 4 OWNERSHIP DOCUMENT 0001213900-25-001357 6768
2025-01-06 4 OWNERSHIP DOCUMENT 0001213900-25-001356 6589
2025-01-06 4 OWNERSHIP DOCUMENT 0001213900-25-001355 6620
2024-12-18 4/A xslF345X05/form4.xml 0000899140-24-001360 4907
2024-12-16 4 xslF345X05/form4.xml 0000899140-24-001355 8066
2024-12-13 4 xslF345X05/form4.xml 0000899140-24-001352 4211
2024-11-25 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-24-102170 001-34673 241496089 34 213962 1 1
2024-11-18 4 xslF345X05/form4.xml 0000899140-24-001286 27690
2024-11-14 144 xsl144X01/primary_doc.xml 0002007317-24-000620 001-34673 241463582 33 4438
2024-11-14 SC 13G/A sayw24111417_13ga.htm 0000905148-24-003179 005-85411 241463329 34 113789
2024-10-30 10-Q QUARTERLY REPORT 0001213900-24-091961 001-34673 241407530 34 4630637 1 1
2024-10-30 8-K CURRENT REPORT 2.02,9.01 0001213900-24-091959 001-34673 241407502 34 268026 1 1
2024-10-08 DEF 14A PROXY STATEMENT 0001213900-24-086301 001-34673 241360832 34 5474232
2024-08-14 10-Q QUARTERLY REPORT 0001213900-24-068600 001-34673 241204304 34 4443143 1 1
2024-08-14 8-K CURRENT REPORT 2.02,9.01 0001213900-24-068589 001-34673 241204239 34 267919 1 1
2024-05-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-05-22 15:00:00 9999999995-24-001622 333-279277 24975073 33 1754
2024-05-20 CORRESP filename1.htm 0001213900-24-045209 6176
2024-05-15 UPLOAD filename1.pdf 0000000000-24-005581 333-279277 40234
2024-05-13 4 xslF345X05/form4.xml 0000899140-24-000577 4231
2024-05-09 S-3 REGISTRATION STATEMENT 0001213900-24-041370 333-279277 24931779 33 936784
2024-05-09 10-Q QUARTERLY REPORT 0001213900-24-041031 001-34673 24928678 34 3888643 1 1
2024-05-09 8-K CURRENT REPORT 2.02,9.01 0001213900-24-041026 001-34673 24928613 34 256860 1 1
2024-03-20 4 xslF345X05/form4.xml 0000899140-24-000326 5032
2024-03-20 4 xslF345X05/form4.xml 0000899140-24-000325 5030
2024-03-20 4 xslF345X05/form4.xml 0000899140-24-000324 5076
2024-03-20 4 xslF345X05/form4.xml 0000899140-24-000323 5018
2024-03-20 4 xslF345X05/form4.xml 0000899140-24-000322 5072
2024-03-20 4 xslF345X05/form4.xml 0000899140-24-000321 5036
2024-03-14 4 xslF345X05/form4.xml 0000899140-24-000302 4819
2024-03-12 10-K ANNUAL REPORT 0001213900-24-021585 001-34673 24740273 34 7273752 1 1
2024-03-12 8-K CURRENT REPORT 2.02,9.01 0001213900-24-021573 001-34673 24740202 34 288662 1 1
2024-02-14 SC 13G/A sayw24021446_13ga.htm 0000905148-24-000628 005-85411 24633830 34 104011
2024-02-13 SC 13G SCHEDULE 13G 0001104659-24-020685 005-85411 24627852 34 13001
2024-01-30 8-K CURRENT REPORT 8.01,9.01 0001213900-24-008015 001-34673 24579703 34 240712 1 1
2024-01-29 SC 13G us21900c3088_012924.txt 0001086364-24-005156 005-85411 24573139 34 13294
2024-01-18 4/A xslF345X05/form4.xml 0000929638-24-000160 4086
2024-01-17 4 xslF345X05/form4.xml 0000929638-24-000134 8612
2024-01-17 4 xslF345X05/form4.xml 0000929638-24-000133 8489
2024-01-17 4 xslF345X05/form4.xml 0000929638-24-000132 8478
2024-01-17 4 xslF345X05/form4.xml 0000929638-24-000131 8508
2023-12-18 4 xslF345X05/form4.xml 0000929638-23-003434 5521
2023-12-15 8-K CURRENT REPORT 5.02 0001213900-23-095909 001-34673 231488902 34 197786 1 1
2023-12-14 4 xslF345X05/form4.xml 0000929638-23-003428 6956
2023-12-14 3 xslF345X02/form3.xml 0000929638-23-003427 2759
2023-11-21 4 xslF345X05/form4.xml 0000929638-23-003205 4118
2023-11-17 4 xslF345X05/form4.xml 0000929638-23-003170 8025
2023-11-16 8-K CURRENT REPORT 8.01,9.01 0001213900-23-087921 001-34673 231414716 34 232936 1 1
2023-11-14 10-Q QUARTERLY REPORT 0001213900-23-086981 001-34673 231406688 34 4031223 1 1
2023-11-14 8-K CURRENT REPORT 2.02,9.01 0001213900-23-086937 001-34673 231406215 34 271313 1 1
2023-10-30 8-K CURRENT REPORT 5.07 0001213900-23-081561 001-34673 231360794 34 205919 1 1
2023-09-13 ARS ANNUAL REPORT 0001213900-23-076433 001-34673 231253562 34 549114
2023-09-13 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-23-076432 001-34673 231253556 34 1748485
2023-09-13 DEF 14A PROXY STATEMENT 0001213900-23-076420 001-34673 231253514 34 5121482
2023-09-08 4 xslF345X05/form4.xml 0000929638-23-002490 4736
2023-08-17 8-K CURRENT REPORT 5.02 0001213900-23-068356 001-34673 231179877 34 198074 1 1
2023-08-08 10-Q QUARTERLY REPORT 0001213900-23-064244 001-34673 231149432 34 4818745 1 1
2023-08-08 8-K CURRENT REPORT 2.02,9.01 0001213900-23-064241 001-34673 231149376 34 274428 1 1
2023-06-30 8-K CURRENT REPORT 8.01,9.01 0001213900-23-053572 001-34673 231062341 34 724077 1 1
2023-06-30 424B5 PROSPECTUS SUPPLEMENT 0001213900-23-053567 333-258756 231062318 33 484082
2023-06-28 424B5 PRELIMINARY PROSPECTUS SUPPLEMENT 0001213900-23-052506 333-258756 231053138 33 484700
2023-06-21 8-K CURRENT REPORT 8.01,9.01 0001213900-23-050240 001-34673 231027467 34 217517 1 1
2023-05-19 4 xslF345X04/form4.xml 0000929638-23-001538 6427
2023-05-18 4/A xslF345X04/form4.xml 0000929638-23-001532 5098
2023-05-18 4/A xslF345X04/form4.xml 0000929638-23-001531 5110
2023-05-18 4/A xslF345X04/form4.xml 0000929638-23-001529 4520
2023-05-18 4/A xslF345X04/form4.xml 0000929638-23-001527 4630
2023-05-17 4 xslF345X04/form4.xml 0000929638-23-001521 4650
2023-05-17 4 xslF345X04/form4.xml 0000929638-23-001520 4662
2023-05-17 4 xslF345X04/form4.xml 0000929638-23-001519 4038
2023-05-17 4 xslF345X04/form4.xml 0000929638-23-001517 4148
2023-05-16 8-K CURRENT REPORT 8.01,9.01 0001213900-23-040128 001-34673 23925554 34 235841 1 1
2023-05-15 10-Q QUARTERLY REPORT 0001213900-23-039793 001-34673 23922596 34 3607603 1 1
2023-05-15 8-K CURRENT REPORT 2.02,9.01 0001213900-23-039770 001-34673 23922281 34 258794 1 1
2023-05-12 4 xslF345X04/form4.xml 0000929638-23-001441 4147
2023-04-26 8-K CURRENT REPORT 8.01,9.01 0001213900-23-032876 001-34673 23850745 34 223248 1 1
2023-04-17 4 xslF345X04/form4.xml 0000929638-23-001181 7270
2023-04-17 3 xslF345X02/form3.xml 0000929638-23-001180 3250
2023-04-17 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-23-030043 001-34673 23822954 34 224987 1 1
2023-03-30 10-K ANNUAL REPORT 0001213900-23-024310 001-34673 23777277 34 6800685 1 1
2023-03-30 8-K CURRENT REPORT 2.02,9.01 0001213900-23-024301 001-34673 23777190 34 279885 1 1
2023-03-03 8-K CURRENT REPORT 8.01,9.01 0001213900-23-016996 001-34673 23701560 34 229231 1 1
2023-02-14 SC 13G/A SC 13G/A 0001140361-23-006660 005-85411 23624228 34 101650
2023-01-20 4 FORM 4 0001567619-23-001095 5946
2023-01-20 3 FORM 3 0001567619-23-001094 3571
2023-01-18 4 OWNERSHIP DOCUMENT 0001213900-23-003557 6064
2023-01-18 4 OWNERSHIP DOCUMENT 0001213900-23-003556 6075
2023-01-18 4 OWNERSHIP DOCUMENT 0001213900-23-003555 7454
2023-01-18 4 OWNERSHIP DOCUMENT 0001213900-23-003554 5926
2023-01-18 4 OWNERSHIP DOCUMENT 0001213900-23-003553 7763
2023-01-18 4 OWNERSHIP DOCUMENT 0001213900-23-003552 6164
2023-01-18 4 OWNERSHIP DOCUMENT 0001213900-23-003550 5979
2023-01-18 4 xslF345X03/ownership.xml 0001213900-23-003549 5292
2023-01-18 4 OWNERSHIP DOCUMENT 0001213900-23-003547 6088
2023-01-18 4 OWNERSHIP DOCUMENT 0001213900-23-003546 5346
2022-11-16 4 xslF345X03/ownership.xml 0001213900-22-073225 4989
2022-11-10 10-Q QUARTERLY REPORT 0001213900-22-070834 001-34673 221375074 34 3790928 1 1
2022-11-10 8-K CURRENT REPORT 2.02,9.01 0001213900-22-070820 001-34673 221374984 34 291227 1 1
2022-10-26 S-8 REGISTRATION STATEMENT 0001213900-22-066518 333-268019 221333672 33 204443
2022-10-21 8-K CURRENT REPORT 4.01,9.01 0001213900-22-065539 001-34673 221324053 34 204124 1 1
2022-10-17 8-K CURRENT REPORT 5.07 0001213900-22-064356 001-34673 221313990 34 210348 1 1
2022-08-30 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-22-052257 001-34673 221214541 34 3711298
2022-08-30 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-22-052252 001-34673 221214479 34 4185814
2022-08-25 4 PRIMARY DOCUMENT 0001213900-22-050936 5169
2022-08-11 10-Q QUARTERLY REPORT 0001213900-22-046617 001-34673 221153809 34 4606693 1 1
2022-08-11 8-K CURRENT REPORT 2.02,9.01 0001213900-22-046610 001-34673 221153748 34 281098 1 1
2022-08-09 8-K CURRENT REPORT 8.01,9.01 0001213900-22-045631 001-34673 221146818 34 235189 1 1
2022-07-08 SC 13G us21900c3088_070822.txt 0000834237-22-010282 005-85411 221075014 34 12146
2022-05-18 4 xslF345X03/ownership.xml 0001213900-22-027983 16319
2022-05-17 4 PRIMARY DOCUMENT 0001213900-22-027450 5852
2022-05-12 4 PRIMARY DOCUMENT 0001213900-22-025973 7693
2022-05-12 10-Q QUARTERLY REPORT 0001213900-22-025967 001-34673 22918250 34 4121724 1 1
2022-05-12 8-K CURRENT REPORT 2.02,8.01,9.01 0001213900-22-025946 001-34673 22917956 34 277572 1 1
2022-03-29 10-K ANNUAL REPORT 0001213900-22-015852 001-34673 22781313 34 6690606 1 1
2022-03-29 8-K CURRENT REPORT 2.02,9.01 0001213900-22-015837 001-34673 22780872 34 292381 1 1
2022-03-28 8-K CURRENT REPORT 8.01,9.01 0001213900-22-015306 001-34673 22773298 34 240558 1 1
2022-03-22 3 PRIMARY DOCUMENT 0001213900-22-014174 2909
2022-03-21 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-22-013742 001-34673 22754279 34 558865 1 1
2022-02-28 8-K CURRENT REPORT 8.01,9.01 0001213900-22-009595 001-34673 22684197 34 4837348 1 1
2022-02-23 4 xslF345X03/form4.xml 0000929638-22-000532 40469
2022-02-23 4 PRIMARY DOCUMENT 0001213900-22-008970 10049
2022-02-23 4 PRIMARY DOCUMENT 0001213900-22-008962 10031
2022-02-23 4 PRIMARY DOCUMENT 0001213900-22-008959 12304
2022-02-23 4 PRIMARY DOCUMENT 0001213900-22-008953 15390
2022-02-23 4 PRIMARY DOCUMENT 0001213900-22-008949 15249
2022-02-23 4 PRIMARY DOCUMENT 0001213900-22-008943 8782
2022-02-23 4 PRIMARY DOCUMENT 0001213900-22-008940 16475
2022-02-23 4 PRIMARY DOCUMENT 0001213900-22-008936 16036
2022-02-23 4 PRIMARY DOCUMENT 0001213900-22-008933 12842
2022-02-14 SC 13G SC 13G 0001104659-22-022934 005-85411 22633067 34 62546
2022-02-03 SC 13G/A us21900c3088_020222.txt 0000834237-22-005532 005-85411 22585808 34 13089
2021-12-29 4 PRIMARY DOCUMENT 0001213900-21-067924 18913
2021-12-23 8-K CURRENT REPORT 5.02,9.01 0001213900-21-067336 001-34673 211517698 34 246596 1 1
2021-12-13 8-K CURRENT REPORT 5.07 0001213900-21-064982 001-34673 211488321 34 227989 1 1
2021-12-07 4 PRIMARY DOCUMENT 0001213900-21-064007 11164
2021-12-07 4 PRIMARY DOCUMENT 0001213900-21-064006 11164
2021-11-19 4 PRIMARY DOCUMENT 0001213900-21-060879 13894
2021-11-19 4 PRIMARY DOCUMENT 0001213900-21-060724 11164
2021-11-10 4 PRIMARY DOCUMENT 0001213900-21-058209 11167
2021-11-09 10-Q QUARTERLY REPORT 0001213900-21-057751 001-34673 211392706 34 4550344 1 1
2021-11-09 8-K CURRENT REPORT 2.02,9.01 0001213900-21-057729 001-34673 211392324 34 280938 1 1
2021-11-03 4 PRIMARY DOCUMENT 0001213900-21-056529 14466
2021-10-29 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-21-055530 001-34673 211364399 34 501638
2021-10-29 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-21-055427 001-34673 211363309 34 3749469
2021-10-29 8-K CURRENT REPORT 5.02,9.01 0001213900-21-055420 001-34673 211363244 34 221909 1 1
2021-10-05 8-K CURRENT REPORT 5.02 0001013762-21-000153 001-34673 211304612 34 201744 1 1
2021-09-07 8-K CURRENT REPORT 8.01,9.01 0001213900-21-046789 001-34673 211238348 34 241147 1 1
2021-08-20 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-08-20 15:00:00 9999999995-21-003271 333-258756 211195174 33 1706
2021-08-18 CORRESP filename1.htm 0001213900-21-043616 7222
2021-08-18 UPLOAD filename1.pdf 0000000000-21-010141 40160
2021-08-12 8-K FORM 8-K 8.01,9.01 0001213900-21-042113 001-34673 211168678 34 489047 1 1
2021-08-12 424B5 PROSPECTUS SUPPLEMENT 0001213900-21-042062 333-249901 211168063 33 415497
2021-08-12 S-3 REGISTRATION STATEMENT 0001213900-21-042058 333-258756 211168000 33 413931
2021-08-12 8-K FORM 8-K 2.02,9.01 0001213900-21-042053 001-34673 211167915 34 270064 1 1
2021-08-12 10-Q QUARTERLY REPORT 0001213900-21-042026 001-34673 211167645 34 4529312 1 1
2021-05-25 4 xslF345X03/ownership.xml 0001213900-21-029080 14409
2021-05-20 4 xslF345X03/ownership.xml 0001213900-21-028172 7743
2021-05-20 3 xslF345X02/ownership.xml 0001213900-21-028169 2900
2021-05-19 4 xslF345X03/ownership.xml 0001213900-21-027991 13445
2021-05-14 8-K FORM 8-K 8.01,9.01 0001213900-21-026172 001-34673 21921110 34 210829 1 1
2021-05-14 8-K FORM 8-K 2.02,9.01 0001213900-21-026169 001-34673 21921104 34 293091 1 1
2021-05-13 10-Q QUARTERLY REPORT 0001213900-21-026113 001-34673 21920211 34 4013990 1 1
2021-04-15 8-K CURRENT REPORT 8.01,9.01 0001213900-21-021646 001-34673 21827573 34 223570 1 1
2021-03-30 8-K CURRENT REPORT 2.02,9.01 0001213900-21-018717 001-34673 21786878 34 317056 1 1
2021-03-30 10-K ANNUAL REPORT 0001213900-21-018684 001-34673 21786855 34 7952543 1 1
2021-03-12 8-K CURRENT REPORT 5.02,9.01 0001213900-21-015144 001-34673 21738102 34 409392 1 1
2021-03-01 8-K CURRENT REPORT 8.01,9.01 0001213900-21-012383 001-34673 21694415 34 221744 1 1
2021-02-11 SC 13D/A CORMEDIX INC. 0000902664-21-001211 005-85411 21621012 34 39551
2021-02-05 424B5 PROSPECTUS SUPPLEMENT 0001213900-21-007111 333-249901 21596664 33 9294
2021-02-02 CERT 8A_Cert_CRMD.pdf 0001354457-21-000139 001-34673 21579230 34 230842
2021-02-02 8-A12B 8-A12B 0001213900-21-005981 001-34673 21579125 34 15449
2021-02-01 25 FORM 25 0001213900-21-005753 001-34673 21576674 34 14074
2021-01-29 SC 13G/A us21900c3088_012921.txt 0000834237-21-003887 005-85411 21568698 34 13027
2021-01-21 8-K CURRENT REPORT 3.01,9.01 0001213900-21-003335 001-34673 21540478 34 238432 1 1
2021-01-13 4 PRIMARY DOCUMENT 0001213900-21-002078 19228
2021-01-13 4 PRIMARY DOCUMENT 0001213900-21-002076 14842
2021-01-13 4 PRIMARY DOCUMENT 0001213900-21-002074 11083
2021-01-13 4 PRIMARY DOCUMENT 0001213900-21-002066 14037
2021-01-13 4 PRIMARY DOCUMENT 0001213900-21-002064 13875
2021-01-13 4 PRIMARY DOCUMENT 0001213900-21-002062 8687
2021-01-13 4 PRIMARY DOCUMENT 0001213900-21-002060 43220
2021-01-13 4 PRIMARY DOCUMENT 0001213900-21-002058 8715
2021-01-13 4 PRIMARY DOCUMENT 0001213900-21-002054 14941
2021-01-13 4 PRIMARY DOCUMENT 0001213900-21-002052 12787
2021-01-13 4 PRIMARY DOCUMENT 0001213900-21-002050 9499
2020-12-18 8-K CURRENT REPORT 5.07 0001213900-20-043490 001-34673 201400651 34 207516 1 1
2020-11-27 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-039655 333-249901 201355556 33 411037
2020-11-27 8-K CURRENT REPORT 8.01,9.01 0001213900-20-039648 001-34673 201355542 34 523354 1 1
2020-11-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-11-25 15:00:00 9999999995-20-003317 333-249901 201352660 33 1706
2020-11-23 CORRESP filename1.htm 0001213900-20-038811 7313
2020-11-18 4 PRIMARY DOCUMENT 0001213900-20-037972 41656
2020-11-18 8-K CURRENT REPORT 8.01,9.01 0001213900-20-037907 001-34673 201323945 34 241110 1 1
2020-11-12 UPLOAD filename1.pdf 0000000000-20-010854 40164
2020-11-05 S-3 REGISTRATION STATEMENT 0001213900-20-035340 333-249901 201292428 33 447201
2020-11-05 8-K FORM 8-K 2.02,9.01 0001213900-20-035323 001-34673 201291256 34 277652 1 1
2020-11-05 10-Q QUARTERLY REPORT 0001213900-20-035310 001-34673 201291098 34 4757239 1 1
2020-11-04 4 PRIMARY DOCUMENT 0001213900-20-035045 8017
2020-11-04 3 PRIMARY DOCUMENT 0001213900-20-035039 2895
2020-11-04 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-20-035037 001-34673 201287359 34 1259765
2020-11-02 8-K FORM 8-K 5.02,8.01,9.01 0001213900-20-034539 001-34673 201280824 34 187596 1 1
2020-10-14 8-K CURRENT REPORT 5.03,9.01 0001213900-20-031268 001-34673 201239408 34 279671 1 1
2020-09-17 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-20-027056 001-34673 201180230 34 245831 1 1
2020-09-17 4 PRIMARY DOCUMENT 0001213900-20-027050 8044
2020-09-17 3 PRIMARY DOCUMENT 0001213900-20-027048 2922
2020-09-09 4 PRIMARY DOCUMENT 0001213900-20-025735 14065
2020-09-08 4 PRIMARY DOCUMENT 0001213900-20-025532 7769
2020-09-04 4 PRIMARY DOCUMENT 0001213900-20-025324 12766
2020-08-31 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-024452 333-223562 201149884 33 9348
2020-08-31 8-K CURRENT REPORT 8.01,9.01 0001213900-20-024450 001-34673 201149881 34 233485 1 1
2020-08-20 4 PRIMARY DOCUMENT 0001213900-20-023158 17166
2020-08-17 4 PRIMARY DOCUMENT 0001213900-20-022579 20767
2020-08-17 4 PRIMARY DOCUMENT 0001213900-20-022574 40339
2020-08-17 4 PRIMARY DOCUMENT 0001213900-20-022568 11054
2020-08-17 4 PRIMARY DOCUMENT 0001213900-20-022562 12768
2020-08-17 4 PRIMARY DOCUMENT 0001213900-20-022546 13664
2020-08-14 4 PRIMARY DOCUMENT 0001213900-20-022353 9580
2020-08-10 8-K CURRENT REPORT 2.02,9.01 0001213900-20-021200 001-34673 201090334 34 319109 1 1
2020-08-10 10-Q QUARTERLY REPORT 0001213900-20-021151 001-34673 201089263 34 4954300 1 1
2020-08-10 SC 13D CORMEDIX INC. 0000902664-20-002925 005-85411 201087240 34 56118
2020-07-29 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-20-019062 001-34673 201057614 34 264458
2020-07-29 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-019055 333-223562 201057559 33 544411
2020-07-27 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-018717 333-223562 201050574 33 540942
2020-07-08 8-K CURRENT REPORT 8.01,9.01 0001213900-20-016924 001-34673 201017331 34 42593
2020-05-18 4 PRIMARY DOCUMENT 0001213900-20-012825 39021
2020-05-18 4 PRIMARY DOCUMENT 0001213900-20-012822 12767
2020-05-13 4 PRIMARY DOCUMENT 0001213900-20-012021 18700
2020-05-13 4 PRIMARY DOCUMENT 0001213900-20-012013 14021
2020-05-13 4 PRIMARY DOCUMENT 0001213900-20-012005 11965
2020-05-13 4 PRIMARY DOCUMENT 0001213900-20-011996 7953
2020-05-13 3 PRIMARY DOCUMENT 0001213900-20-011990 2964
2020-05-11 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-20-011685 001-34673 20865746 34 61702
2020-05-11 10-Q QUARTERLY REPORT 0001213900-20-011675 001-34673 20865653 34 3273294 1
2020-05-11 8-K ea121653_8k.htm 2.02,9.01 0001213900-20-011647 001-34673 20865160 34 73051
2020-04-23 8-K CURRENT REPORT 5.02,9.01 0001213900-20-009879 001-34673 20809238 34 153037
2020-04-22 8-K CURRENT REPORT 8.01,9.01 0001213900-20-009782 001-34673 20806767 34 54113
2020-04-08 8-K CURRENT REPORT 8.01,9.01 0001213900-20-008790 001-34673 20780698 34 35942
2020-03-19 4 PRIMARY DOCUMENT 0001213900-20-006882 8071
2020-03-18 4 PRIMARY DOCUMENT 0001213900-20-006779 13207
2020-03-16 8-K CURRENT REPORT 2.02,9.01 0001213900-20-006527 001-34673 20717986 34 116060
2020-03-16 10-K ANNUAL REPORT 0001213900-20-006521 001-34673 20717931 34 5266097 1
2020-02-27 4 PRIMARY DOCUMENT 0001213900-20-004982 21881
2020-02-27 4 PRIMARY DOCUMENT 0001213900-20-004981 37705
2020-02-27 4 PRIMARY DOCUMENT 0001213900-20-004980 10793
2020-02-27 4 PRIMARY DOCUMENT 0001213900-20-004979 8073
2020-02-27 4 PRIMARY DOCUMENT 0001213900-20-004978 12311
2020-02-27 4 PRIMARY DOCUMENT 0001213900-20-004977 13209
2020-02-27 4 PRIMARY DOCUMENT 0001213900-20-004975 14806
2020-02-27 4 PRIMARY DOCUMENT 0001213900-20-004974 10012
2020-02-27 4 PRIMARY DOCUMENT 0001213900-20-004972 9972
2020-02-20 4/A PRIMARY DOCUMENT 0001213900-20-004441 35950

Latest XBRL company facts

One latest value per concept from companyfacts (616 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 79.54M 2026-11-09 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
dei EntityPublicFloat Entity Public Float USD 909.70M 2025-06-30 2025 FY 10-K 2026-03-05 0001213900-26-023889
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 5.02M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001213900-26-049311
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.75M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001213900-26-049311
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 275.59 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001213900-26-049311
srt StockRepurchaseProgramAuthorizedAmount1 StockRepurchaseProgramAuthorizedAmount1 USD 75.00M 2026-02-02 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 2.50M 2020-03-31 2020 Q1 10-Q 2020-05-11 0001213900-20-011675
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 2.40M 2020-06-30 2020 Q2 10-Q 2020-08-10 0001213900-20-021151
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 10.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 2.40M 2019-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 76.71M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 12,918 2017-03-31 2017 Q1 10-Q 2017-05-10 0001654954-17-004357
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 173.63M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 23.27M 2025-03-31 2025 Q1 10-Q 2025-05-06 0001213900-25-039908
us-gaap AccruedLiabilitiesFairValueDisclosure Accrued Liabilities, Fair Value Disclosure USD 2.52M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001213900-20-035310
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 10.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 5.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 10,000 2014-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 674,000 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-001852
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 588.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 218.94M 2019-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 396,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 143,431 2018-01-01 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 1.33M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition USD 4.07M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 676,614 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001213900-20-011675
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 12.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 128,625 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 154,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064244
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 615,000 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 0 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2026-01-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 398,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 51,253 2006-07-28 2014-03-31 2014 Q1 10-Q 2014-05-15 0001354488-14-002703
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 13.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap AmountOfImpairmentToCarryingAmountOfRegulatoryAssets Amount of Impairment to Carrying Amount of Regulatory Assets EUR 10,000 2023-02-08 2023 Q1 10-Q 2023-05-15 0001213900-23-039793
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount USD/shares 2.27 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap AssetAcquisitionConsiderationTransferredContingentConsideration AssetAcquisitionConsiderationTransferredContingentConsideration USD 43.20M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064244
us-gaap Assets Assets USD 917.75M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AssetsCurrent Assets, Current USD 502.99M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2025-12-31 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2025-12-31 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 8.50M 2025-12-31 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap AvailableForSaleEquitySecuritiesAmortizedCostBasis Available-for-sale Equity Securities, Amortized Cost Basis USD 22.62M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap AvailableForSaleEquitySecuritiesGrossUnrealizedGain Available-for-sale Equity Securities, Gross Unrealized Gain USD 199 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap AvailableForSaleEquitySecuritiesGrossUnrealizedLoss Available-for-sale Equity Securities, Gross Unrealized Loss USD 854 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 22.62M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 22.62M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 8.50M 2025-12-31 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap BasicEarningsPerShareProForma Basic Earnings Per Share, Pro Forma USD/shares -1.51 2018-01-01 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares shares 29,109 2008-12-01 2008-12-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap BusinessAcquisitionProFormaEarningsPerShareBasic Business Acquisition, Pro Forma Earnings Per Share, Basic USD/shares 1.76 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap BusinessAcquisitionProFormaEarningsPerShareDiluted Business Acquisition, Pro Forma Earnings Per Share, Diluted USD/shares 1.63 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax USD 123.67M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 272.71M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset USD -22.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 6.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net USD 9.30M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 874,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap Cash Cash USD 2.00M 2019-08-14 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 355.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -4.15M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001213900-20-011675
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 356.14M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations USD 43.82M 2023-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 210.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 38.83M 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064244
us-gaap ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments USD -4.66M 2014-04-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001354488-14-004247
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Warrants 1.5 2013-02-19 2013 Q1 10-Q 2013-05-15 0001144204-13-029499
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 6.22 2019-09-30 2019 Q3 10-Q 2019-11-14 0001213900-19-023505
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 3.31M 2012-12-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2023-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2014-06-30 2014 Q2 10-Q 2014-08-14 0001354488-14-004247
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 556,069 2021-02-28 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 160.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 79.48M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 79.48M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 15.20M 2019-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap CommonStockValue Common Stock, Value, Issued USD 79,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap CompensatingBalanceAmount Compensating Balance, Amount USD 20.40M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039793
us-gaap CompensationExpenseExcludingCostOfGoodAndServiceSold Compensation Expense, Excluding Cost of Good and Service Sold USD 362,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001213900-24-041031
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap ConcentrationRiskPercentage1 Concentration Risk, Percentage pure 0.1 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 900,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 49.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap ConvertibleDebt Convertible Debt USD 16,061 2012-12-31 2013 FY 10-K 2014-03-31 0001354488-14-001544
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 144,626 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 6.13M 2018-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization USD 40.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 59,700 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001654954-17-010329
us-gaap CostOfRevenue Cost of Revenue USD 12.01M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001410098-26-000021
us-gaap CostsAndExpenses Costs and Expenses USD 3.16M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-070834
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 4.80M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001213900-20-035310
us-gaap CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) USD -84,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 2.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 12.76M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 10.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DebtAndEquitySecuritiesGainLoss Debt and Equity Securities, Gain (Loss) USD 150.00M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039793
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 457,000 2013-01-01 2013-06-30 2013 Q2 10-Q/A 2014-03-04 0001354488-14-000974
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD -2.45M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001354488-14-005681
us-gaap DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 Debt Instrument, Convertible, Threshold Consecutive Trading Days Days 30 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger pure 0.1 2019-08-01 2019-08-14 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 1,000 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 0 2014-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.09 2012-11-13 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 5,374 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap DecreaseInRestrictedCash Decrease in Restricted Cash USD 48,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap DeferredCompensationEquity Deferred Compensation Equity USD 110 2015-12-31 2015 FY 10-K 2016-03-15 0001354488-16-006585
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -28.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 0 2014-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 5.70M 2025-08-12 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 0 2014-09-30 2014 Q3 10-Q 2014-11-13 0001354488-14-005681
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 18.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 51.49M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 2.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap DeferredRentCredit Deferred Rent Credit USD 1,654 2014-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 3,105 2014-09-30 2014 Q3 10-Q 2014-11-13 0001354488-14-005681
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 403 2014-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap DeferredRevenue Deferred Revenue USD 4,400 2019-09-30 2019 Q3 10-Q 2019-11-14 0001213900-19-023505
us-gaap DeferredRevenueAdditions Deferred Revenue, Additions USD 50,000 2014-08-01 2014-08-14 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 2,206 2019-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 0 2016-12-31 2016 FY 10-K 2017-03-16 0001654954-17-002094
us-gaap DeferredRevenueRefundPayments1 Deferred Revenue, Refund Payments USD 50,000 2014-08-01 2014-08-31 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 2,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 3.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 0 2014-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 181.09M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 256,000 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 16.28M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 67.76M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 52.99M 2021-12-31 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 117.14M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 10,000 2024-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 37.81M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 616,000 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 3.38M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 172,000 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3.95M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Returns and Allowances USD 1.38M 2025-03-31 2025 Q1 10-Q 2025-05-06 0001213900-25-039908
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 113.33M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 36.28M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 15.21M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 145.42M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 44,390 2006-07-28 2012-12-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.03 2010-04-29 2010-05-02 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap DepositAssets Deposit Assets USD 500,822 2020-09-30 2020 Q3 10-Q 2020-11-05 0001213900-20-035310
us-gaap Deposits Deposits USD 50,000 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039793
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 20,000 2020-12-31 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 20,000 2019-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap Depreciation Depreciation USD 677,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 31.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 5.31M 2013-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 8.85M 2013-01-01 2013-09-30 2014 Q3 10-Q 2014-11-13 0001354488-14-005681
us-gaap DerivativeLiabilities Derivative Liability USD 1.88M 2017-06-30 2017 Q2 10-Q 2017-08-09 0001654954-17-007136
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2014-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap DerivativeUnderlyingInvestmentShares DerivativeUnderlyingInvestmentShares shares 2.50M 2024-09-30 2024 Q3 10-Q 2024-10-30 0001213900-24-091961
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 76.20M 2014-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap DilutedEarningsPerShareProForma Diluted Earnings Per Share Pro Forma USD/shares -1.51 2018-01-01 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap Dividends Dividends USD -33,121 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001354488-15-004982
us-gaap DividendsCommonStock Dividends, Common Stock USD 27,452 2014-04-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001354488-14-004247
us-gaap DividendsPayableCurrent Dividends Payable, Current USD 0 2014-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD -54,602 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001354488-14-004247
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.63 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.75 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.57 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.36 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.405 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0.8 2017-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap EffectiveIncomeTaxRateReconciliationDispositionOfAssets Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent pure 0 2012-01-01 2012-12-31 2012 FY 10-K/A 2014-03-04 0001354488-14-000970
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.027 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-001852
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD -851,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.069 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 8.35 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -12,919 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 3.06M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-070834
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.79M 2022-06-30 2022 Q2 10-Q 2022-08-11 0001213900-22-046617
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 3.60M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 1.56M 2013-03-31 2013 Q1 10-Q 2013-05-15 0001144204-13-029499
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 6.50M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086981
us-gaap EmployeeStockOwnershipPlanESOPCompensationExpense Employee Stock Ownership Plan (ESOP), Compensation Expense USD 3.79M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001213900-21-057751
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.05 2008-12-31 2022 Q1 10-Q 2022-05-12 0001213900-22-025967
us-gaap EscrowDeposit Escrow Deposit USD 4.00M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap ExcessStockSharesIssued Excess Stock, Shares Issued shares 1.50M 2023-06-28 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -182,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2013-01-01 2013-09-30 2013 Q3 10-Q/A 2014-03-04 0001354488-14-000976
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 1.176 2013-01-01 2013-09-30 2013 Q3 10-Q/A 2014-03-04 0001354488-14-000976
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.007 2013-01-01 2013-09-30 2013 Q3 10-Q/A 2014-03-04 0001354488-14-000976
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 8.67M 2014-06-30 2014 Q2 10-Q 2014-08-14 0001354488-14-004247
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) USD 8.85M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001654954-17-002094
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss) USD 8.85M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001354488-14-005681
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues USD 3.78M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001354488-14-005681
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 9,293 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 1.14M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 596,000 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 586,000 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 1.27M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 28,196 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 601,814 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 161,678 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 329,363 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 151,238 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 135,708 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 567,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 946,000 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 31,627 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 0 2014-09-30 2014 Q3 10-Q 2014-11-13 0001354488-14-005681
us-gaap FinancingReceivableDeferredIncome Financing Receivable, Deferred Commitment Fee USD 5.30M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD -14.03M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 33,439 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 41,200 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 10.65M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 37,833 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 41,200 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 41,200 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 41,200 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 393.10M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 236,072 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap FiniteLivedLicenseAgreementsGross Finite-Lived License Agreements, Gross USD 2.00M 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068600
us-gaap ForeignCurrencyTransactionGainBeforeTax Foreign Currency Transaction Gain, before Tax USD 1,000 2021-04-01 2021-06-30 2022 Q2 10-Q 2022-08-11 0001213900-22-046617
us-gaap ForeignCurrencyTransactionGainLossAfterTax ForeignCurrencyTransactionGainLossAfterTax USD -100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -52,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD 86,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 22,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-070834
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -5,633 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001213900-20-011675
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001354488-15-004982
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 54.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap Goodwill Goodwill USD 30.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD 1,682 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap GrossProfit Gross Profit USD 212.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap IncomeLossAttributableToParent Income (Loss) Attributable to Parent, before Tax USD 77.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD 1.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 150.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 77.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -259,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -27.20M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -46.34M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -4.79M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001213900-20-011675
us-gaap IncomeTaxesPaid Income Taxes Paid USD 6,276 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001213900-20-011675
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 62,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 28.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants Income Tax (Expense) Benefit, Continuing Operations, Government Grants USD -30.29M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -60.71M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 57,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 31.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 507,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 936,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 79,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 10.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 698,353 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064244
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -94.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001354488-14-005681
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 10.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap IncreaseDecreaseInDeferredCompensation Increase (Decrease) in Deferred Compensation USD 62,250 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 2,206 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-12 0001213900-21-042026
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD 1.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -2,206 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap IncreaseDecreaseInDepositsOutstanding Increase (Decrease) in Deposits Outstanding USD 13,342 2006-07-28 2014-03-31 2014 Q1 10-Q 2014-05-15 0001354488-14-002703
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 3.78M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001654954-17-002094
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001354488-14-005681
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 13.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap IncreaseDecreaseInMaterialsAndSupplies Increase (Decrease) in Materials and Supplies USD -44,006 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -308,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 328,578 2006-07-28 2013-06-30 2013 Q2 10-Q/A 2014-03-04 0001354488-14-000974
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -32,422 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039793
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 11.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 86,191 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001354488-15-004982
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -42,143 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001654954-17-002094
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD 126,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039793
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 95,286 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 11.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 2.25M 2014-04-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001354488-14-004247
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 2.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap InsuranceRecoveries Insurance Recoveries USD 5.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap InsuranceSettlementsReceivableCurrent Insurance Settlements Receivable, Current USD 500,000 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068600
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 348.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 462,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap InterestCostsIncurred Interest Costs Incurred USD 187,500 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-11 0001213900-20-011675
us-gaap InterestExpense Interest Expense USD 16,391 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068600
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 2.78M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 1.40M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-001852
us-gaap InterestIncomeOther Interest Income, Other USD 1.51M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068600
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 12,552 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 5.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap InterestPayableCurrent Interest Payable, Current USD 1.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 14.84M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap InventoryGross Inventory, Gross USD 270,506 2013-09-30 2013 Q3 10-Q/A 2014-03-04 0001354488-14-000976
us-gaap InventoryLIFOReserve Inventory, LIFO Reserve USD 172,941 2021-06-30 2021 Q2 10-Q 2021-08-12 0001213900-21-042026
us-gaap InventoryLIFOReserveEffectOnIncomeNet Inventory, LIFO Reserve, Effect on Income, Net USD 27,163 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap InventoryNet Inventory, Net USD 43.14M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 12.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap InventoryRawMaterialsAndPurchasedPartsNetOfReserves Inventory, Raw Materials and Purchased Parts, Net of Reserves USD 54,000 2014-09-30 2014 Q3 10-Q 2014-11-13 0001354488-14-005681
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 103,000 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 16.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 3.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap InvestmentIncomeOperatingTaxExpenseBenefit InvestmentIncomeOperatingTaxExpenseBenefit USD 1.53M 2023-01-01 2023-12-31 2024 Q2 10-Q 2024-08-14 0001213900-24-068600
us-gaap InvestmentsAndCash Investments and Cash USD 55.70M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 158,262 2006-07-28 2014-03-31 2014 Q1 10-Q 2014-05-15 0001354488-14-002703
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 43,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001654954-17-010329
us-gaap LeaseCost Lease, Cost USD 245,981 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap LegalFees Legal Fees USD 267,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 4.04M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 1.31M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 905,946 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 208,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001213900-22-025967
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 169,000 2023-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 723,270 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 877,838 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 224,792 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 789,309 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 5.00M 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-001852
us-gaap Liabilities Liabilities USD 456.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 917.75M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 2.00M 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-072843
us-gaap LiabilitiesCurrent Liabilities, Current USD 207.29M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 15.00M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities Liquidation Basis of Accounting, Accrued Costs to Dispose of Assets and Liabilities USD 104.40M 2023-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 10.36M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 182,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap MaterialsSuppliesAndOther Materials, Supplies, and Other USD 9.05M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -8.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 491,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 218.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 49.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 28.20M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD 150.70M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 49.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 49.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31) USD 16,624 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-14 0001213900-19-023505
us-gaap NoncashOrPartNoncashAcquisitionAccountsReceivableAcquired1 Noncash or Part Noncash Acquisition, Accounts Receivable Acquired USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -22.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap OfficersCompensation Salary and Wage, Officer, Excluding Cost of Good and Service Sold USD 250,000 2011-01-01 2011-01-14 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap OperatingExpenses Operating Expenses USD 112.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 99.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap OperatingLeaseCost Operating Lease, Cost USD 205,061 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 104,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-072843
us-gaap OperatingLeaseLeaseIncome Operating Lease, Lease Income USD 100,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-11 0001213900-22-046617
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 3.26M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 853,000 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 2.25M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap OperatingLeasePayments Operating Lease, Payments USD 212,737 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 3.02M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 438,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 1.34M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 82,697 2012-12-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 208,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 205,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour Operating Leases, Future Minimum Payments, Due in Rolling Year Four USD 1,000 2019-09-30 2019 Q3 10-Q 2019-11-14 0001213900-19-023505
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree Operating Leases, Future Minimum Payments, Due in Rolling Year Three USD 202,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo Operating Leases, Future Minimum Payments, Due in Rolling Year Two USD 200,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 20,894 2012-12-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 83,576 2012-12-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 380,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths Operating Leases, Future Minimum Payments, Next Rolling Twelve Months USD 198,000 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 149,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001213900-21-026113
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.09 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-072843
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 91.5 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 44.20M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 8.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap OtherAdditionalCapital Other Additional Capital USD 50,000 2014-08-31 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap OtherAssets Other Assets USD 642,066 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-072843
us-gaap OtherCommitment Other Commitment USD 30.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 495 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068600
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 6,020 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap OtherComprehensiveIncomeLossBeforeTax Other Comprehensive Income (Loss), before Tax USD -46.34M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax USD 1,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001410098-26-000021
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -6,090 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-06 0001213900-25-039908
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, after Tax USD -5,661 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064244
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD -49.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent USD 1,911 2018-01-01 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD -1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap OtherExpenses Other Expenses USD 1,000 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-10 0001213900-20-021151
us-gaap OtherFiniteLivedIntangibleAssetsGross Other Finite-Lived Intangible Assets, Gross USD 372,454 2020-09-30 2020 Q3 10-Q 2020-11-05 0001213900-20-035310
us-gaap OtherGeneralExpense Other General Expense USD 3.28M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap OtherIncome Other Income USD 500,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068600
us-gaap OtherInterestAndDividendIncome Other Interest and Dividend Income USD 26.73M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap OtherInventory Other Inventory, Gross USD 6.41M 2023-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 2.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap OtherLongTermInvestments Other Long-term Investments USD 28.02M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap OtherNoncashExpense Other Noncash Expense USD 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-14 0001654954-18-009147
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -1.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 519,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 1.99M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068600
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 193,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 2.21M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 493,855 2011-12-31 2012 FY 10-K/A 2014-03-04 0001354488-14-000970
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 36,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001213900-20-035310
us-gaap OtherSalesRevenueNet Other Revenue, Net (Deprecated 2018-01-31) USD 21,004 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001654954-18-005457
us-gaap OtherTaxExpenseBenefit Other Tax Expense (Benefit) USD 626,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 1.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 47,024 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-12 0001213900-21-042026
us-gaap PaymentsForDeposits Payments for Deposits EUR 116,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064244
us-gaap PaymentsForLeasingCosts Payments for Leasing Costs USD 17,000 2020-09-16 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap PaymentsForLegalSettlements Payments for Legal Settlements EUR 46,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086981
us-gaap PaymentsForMergerRelatedCosts Payments for Merger Related Costs USD 10.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap PaymentsForParticipationLiabilities Payments for Participation Liabilities USD 3.00M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD 19.81M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068600
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 17.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PaymentsForRepurchaseOfWarrants Payments for Repurchase of Warrants USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 282,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PaymentsOfDividendsPreferredStockAndPreferenceStock Payments of Ordinary Dividends, Preferred Stock and Preference Stock USD -21,117 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 312,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001410098-26-000056
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 5.73M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 1.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 3.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PaymentsToAcquireRestrictedCertificatesOfDeposit Payments to Acquire Restricted Certificates of Deposit USD 87,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064244
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PostconfirmationOtherPropertyAndEquipment Postconfirmation, Other Property and Equipment USD 4,000 2020-06-30 2020 Q2 10-Q 2020-08-10 0001213900-20-021151
us-gaap PostemploymentBenefitsPeriodExpense Postemployment Benefits, Period Expense USD 4.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001654954-17-002094
us-gaap PreferredStockLiquidationPreference Preferred Stock, Liquidation Preference Per Share USD/shares 0.001 2013-02-19 2013 Q1 10-Q 2013-05-15 0001144204-13-029499
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 5.64M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PreferredStockPerShareAmountsOfPreferredDividendsInArrears Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears USD/shares 10 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 91,623 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 91,623 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PrepaidAdvertising Prepaid Advertising USD 1.03M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 27.99M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 123,116 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-072843
us-gaap PrepaidInsurance Prepaid Insurance USD 1.98M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 150.00M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 586,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 10.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 18.30M 2023-11-01 2023-11-30 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 507,133 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap ProceedsFromIssuanceOfSeniorLongTermDebt Proceeds from Issuance of Senior Long-term Debt USD 7.50M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 42.88M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-25 0001013762-25-001852
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 150.00M 2024-05-09 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap ProceedsFromLegalSettlements Proceeds from Legal Settlements EUR 10,000 2023-10-16 2023 Q3 10-Q 2023-11-14 0001213900-23-086981
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001354488-14-005681
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 2.00M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 3.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 3.69M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001410098-26-000056
us-gaap ProceedsFromSaleOfTradingSecuritiesHeldforinvestment Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment USD 2.12M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 3.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 6,800 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001654954-17-010329
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 3,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap ProfessionalFees Professional Fees USD 2.90M 2020-04-01 2020-04-30 2020 Q3 10-Q 2020-11-05 0001213900-20-035310
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -7.03M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001213900-22-025967
us-gaap ProFormaWeightedAverageSharesOutstandingDiluted Pro Forma Weighted Average Shares Outstanding, Diluted shares 17.82M 2018-01-01 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.87M 2023-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 8.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap PropertyPlantAndEquipmentOtherAccumulatedDepreciation Property, Plant and Equipment, Other, Accumulated Depreciation USD 520,542 2023-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap PropertyPlantAndEquipmentOwnedAccumulatedDepreciation Property, Plant, and Equipment, Owned, Accumulated Depreciation USD 303,279 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap ProvisionForOtherCreditLosses Provision for Other Credit Losses USD 252,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD 3.85M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001654954-17-010329
us-gaap ReimbursementFromLimitedPartnershipInvestment Reimbursement from Limited Partnership Investment USD 30,000 2020-01-01 2020-12-31 2023 Q2 10-Q 2023-08-08 0001213900-23-064244
us-gaap ReinsuranceRetentionPolicyReinsuredRiskPercentage Reinsurance Retention Policy, Reinsured Risk, Percentage pure 0.71 2023-11-15 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 5,000 2012-01-01 2012-09-30 2012 Q3 10-Q/A 2013-03-27 0001144204-13-017899
us-gaap RepaymentOfNotesReceivableFromRelatedParties Repayment of Notes Receivable from Related Parties USD 1.00M 2006-07-28 2014-03-31 2014 Q1 10-Q 2014-05-15 0001354488-14-002703
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 1.98M 2006-07-28 2014-03-31 2014 Q1 10-Q 2014-05-15 0001354488-14-002703
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 20.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 252,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-09 0001654954-17-007136
us-gaap RestatementOfPriorYearIncomeGross Restatement of Prior Year Income, Gross (Deprecated 2020-01-31) USD 325,000 2012-01-01 2012-09-30 2012 Q3 10-Q/A 2013-03-27 0001144204-13-017899
us-gaap RestrictedCash Restricted Cash USD 700,000 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 656,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 332,000 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap RestrictedCashEquivalentsNoncurrent Restricted Cash Equivalents, Noncurrent USD 332,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 105,084 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-072843
us-gaap RestrictedStockExpense Restricted Stock or Unit Expense USD 690,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-001852
us-gaap RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings Restricted Stock, Shares Issued Net of Shares for Tax Withholdings shares 37,443 2023-05-01 2023-05-31 2023 Q2 10-Q 2023-08-08 0001213900-23-064244
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD -1.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -126.71M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap RetainedEarningsAppropriated Retained Earnings, Appropriated USD -260.30M 2022-06-30 2022 Q2 10-Q 2022-08-11 0001213900-22-046617
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 283.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 180.36M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap RevenueOtherManufacturedProducts Revenue Other Manufactured Products (Deprecated 2018-01-31) USD 23,210 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001654954-18-005457
us-gaap Revenues Revenues USD 311.71M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 53,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001410098-26-000056
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 18.90M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-001852
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 2.52M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-10-30 0001213900-24-091961
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 12.87 2025-06-30 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap SalesAndExciseTaxPayableCurrentAndNoncurrent Sales and Excise Tax Payable USD 1,833 2016-12-31 2016 FY 10-K 2017-03-16 0001654954-17-002094
us-gaap SecurityDeposit Security Deposit USD 300,000 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 36.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 15.05M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001213900-24-041031
us-gaap SeniorLongTermNotes Senior Notes, Noncurrent USD 150,000 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 12.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 247,500 2017-12-31 2017 FY 10-K 2018-03-19 0001654954-18-002777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share USD/shares 284,174 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-15 0001354488-16-006585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 10.5 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 62,241 2024-05-31 2024 Q3 10-Q 2024-10-30 0001213900-24-091961
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.989 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-10-30 0001213900-24-091961
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.63 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001654954-19-009628
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.028 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001654954-19-009628
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-10-30 0001213900-24-091961
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.027 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001654954-19-009628
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.023 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001654954-19-009628
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 91,500 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations shares 66,680 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures shares 892,973 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations shares 136,500 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001213900-20-006521
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 450,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other shares -9.89M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-19 0001654954-18-002777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 56,455 2021-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 73,107 2010-12-31 2023 FY 10-K 2024-03-12 0001213900-24-021585
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 746,522 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.82M 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 4.69 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 115,913 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001213900-19-023505
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 31,955 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 90,531 2018-01-01 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 7.16 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value USD/shares 113,348 2018-01-01 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 471,559 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 678,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value USD/shares 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001213900-21-042026
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.09M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001213900-20-035310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.04 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-001852
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 1.55M 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 5.25 2021-12-31 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 2.39M 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-072843
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 4.45M 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price USD/shares 3.62 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-072843
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.21 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 87,520 2021-06-30 2021 Q2 10-Q 2021-08-12 0001213900-21-042026
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 2.64M 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 7.26 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 366,528 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 410,000 2021-06-30 2021 Q2 10-Q 2021-08-12 0001213900-21-042026
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 8.14 2021-09-30 2021 Q3 10-Q 2021-11-09 0001213900-21-057751
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 1.89M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001213900-21-057751
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 3.38 2022-05-01 2022-05-10 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 369,500 2019-09-01 2019-09-25 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 33,220 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 8 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 8.3 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001213900-21-042026
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 3.99 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-072843
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 5.56 2021-10-26 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 4.96 2020-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate pure 1 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate pure 0.003 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap SharePrice Share Price USD/shares 3.04 2024-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap SharesIssued Shares, Issued shares 125,000 2021-10-26 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 5 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024310
us-gaap ShortTermInvestments Short-term Investments USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap SignificantSupplyCommitmentRemainingMinimumAmountCommitted Supply Commitment, Remaining Minimum Amount Committed USD 4.60M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap StandardProductWarrantyAccrualCurrent Standard Product Warranty Accrual, Current USD 582,800 2013-09-30 2013 Q3 10-Q/A 2014-03-04 0001354488-14-000976
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 493,855 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 2,501 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001013762-25-001852
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 461.71M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 53.93M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039793
us-gaap StockIssued1 Stock Issued USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 3.32M 2025-08-29 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 5.91M 2010-03-01 2010-03-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap StockIssuedDuringPeriodSharesConversionOfUnits Stock Issued During Period, Shares, Conversion of Units shares 474,105 2013-02-01 2013-02-22 2013 Q1 10-Q 2013-05-15 0001144204-13-029499
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 828,024 2010-03-01 2010-03-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 47,024 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001213900-20-011675
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares 29,109 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001213900-23-086981
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationGross Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture shares 356,000 2011-03-02 2011-03-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 32,734 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001213900-21-042026
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 40.00M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 0 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001654954-17-010329
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 4.99M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-12 0001354488-15-001120
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 21.26M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 82.37M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 42.88M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-25 0001013762-25-001852
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 43 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-14 0001654954-18-009147
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD -198,442 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064244
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 3.27M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064244
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 453,100 2011-03-02 2011-03-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 3.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 17.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 220,000 2013-02-01 2013-02-28 2013 Q1 10-Q 2013-05-15 0001144204-13-029499
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 5.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 70,269 2021-12-31 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap TradingSecurities Debt Securities, Trading, and Equity Securities, FV-NI USD 104.00M 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064244
us-gaap TradingSecuritiesUnrealizedHoldingLoss Trading Securities, Unrealized Holding Loss USD 1,009 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-13 0001654954-19-005790
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 1.60M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001410098-26-000021
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 17.48M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001410098-26-000056
us-gaap UndistributedEarnings Undistributed Earnings, Basic USD 988,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 314,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap UndistributedEarningsLossAvailableToCommonShareholdersBasic Undistributed Earnings (Loss) Available to Common Shareholders, Basic USD 49.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 8.85M 2014-01-01 2014-09-15 2016 FY 10-K 2017-03-16 0001654954-17-002094
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 2.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001213900-26-023889
us-gaap UnrecordedUnconditionalPurchaseObligationImputedInterest Unrecorded Unconditional Purchase Obligation, Imputed Interest USD 157,000 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064244
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 13.53M 2006-07-28 2012-12-31 2012 FY 10-K 2013-03-27 0001144204-13-017913
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 0.005 2019-12-01 2019-12-31 2020 FY 10-K 2021-03-30 0001213900-21-018684
us-gaap WarrantExercisePriceIncrease Warrant, Exercise Price, Increase USD/shares 0.005 2013-05-02 2013-05-31 2019 Q3 10-Q 2019-11-14 0001213900-19-023505
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 4.01M 2016-12-31 2016 FY 10-K 2017-03-16 0001654954-17-002094
us-gaap WeightedAverageBasicSharesOutstandingProForma Weighted Average Basic Shares Outstanding, Pro Forma shares 17.82M 2018-01-01 2018-12-31 2018 FY 10-K 2019-05-29 0001654954-19-006678
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 70.16M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-108777
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 92.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 37.67M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001213900-22-015852
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 78.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001410098-26-000067
us-gaap WeightedAverageNumberOfSharesRestrictedStock Weighted Average Number of Shares, Restricted Stock shares 207,469 2022-05-01 2022-05-10 2022 FY 10-K 2023-03-30 0001213900-23-024310

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →